{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:50:32Z","timestamp":1791312632327,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Silico Pharmacol."],"DOI":"10.1007\/s40203-026-00765-7","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:53:14Z","timestamp":1791309194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating network pharmacology to investigate the mechanism of esculetin from Nyctanthes arbor-tristis leaves against breast cancer"],"prefix":"10.1007","volume":"14","author":[{"given":"Rohit Singh","family":"Negi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmayee","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet Kumar Sah","family":"Gond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-5935","authenticated-orcid":false,"given":"Sunil Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"765_CR1","first-page":"137","volume":"6","author":"A Borg","year":"1991","unstructured":"Borg A, Baldetorp B, Fern\u00f6 M, Killander D, Olsson H, Sigurdsson H (1991) ERBB2 amplification in breast cancer with a high rate of proliferation. Oncogene 6:137\u2013143","journal-title":"Oncogene"},{"key":"765_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0304-3835(94)90194-5","volume":"81","author":"\u00c5 Borg","year":"1994","unstructured":"Borg \u00c5, Baldetorp B, Fern\u00f6 M, Killander D, Olsson H, Ryden S, Sigurdsson H (1994) ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer. Cancer Lett 81:137\u2013144","journal-title":"Cancer Lett"},{"key":"765_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035306","volume":"102","author":"T Cai","year":"2023","unstructured":"Cai T, Cai B (2023) Pharmacological activities of esculin and esculetin: a review. Medicine 102:e35306","journal-title":"Medicine"},{"key":"765_CR4","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202600321R","volume":"40","author":"S Chaturvedi","year":"2026","unstructured":"Chaturvedi S, Mishra S, Pandya N, Kumar S, Negi R, Singh S, Patel Y, Tiwari S, Patel A, Gupta RK, Mishra SK, Singh A, Tripathi G, Tripathi A, Kumar A, Dubey PK (2026) Targeting mutant phenylalanine hydroxylase with pyrimidine-triazole conjugates: a primary framework for candidate chaperone-based strategies in phenylketonuria. FASEB J 40:e72135. https:\/\/doi.org\/10.1096\/fj.202600321R","journal-title":"FASEB J"},{"key":"765_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1340726","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen X, Keller SJ, Hafner P, Alrawashdeh AY, Avery TY, Norona J, Zhou J, Ruess DA (2024) Tyrosine phosphatase PTPN11\/SHP2 in solid tumors-bull\u2019s eye for targeted therapy? Front Immunol 15:1340726","journal-title":"Front Immunol"},{"key":"765_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0014-2999(01)00859-7","volume":"416","author":"CY Chu","year":"2001","unstructured":"Chu CY, Tsai YY, Wang CJ, Lin WL, Tseng TH (2001) Induction of apoptosis by esculetin in human leukemia cells. Eur J Pharmacol 416:25\u201332. https:\/\/doi.org\/10.1016\/s0014-2999(01)00859-7","journal-title":"Eur J Pharmacol"},{"key":"765_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2026.100959","author":"L Das","year":"2026","unstructured":"Das L, Das M, Hazarika G, Barkalita LM, Borah P, Baro MR, Chetia A (2026) Therapeutic potential of Myrica esculenta fruit extract in attenuating myocardial damage in an isoproterenol-induced experimental model of myocardial infarction in mice. Phytomed plus. https:\/\/doi.org\/10.1016\/j.phyplu.2026.100959","journal-title":"Phytomed plus"},{"key":"765_CR8","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1038\/sj.onc.1203979","volume":"19","author":"A De Luca","year":"2000","unstructured":"De Luca A, Arra C, D\u2019Antonio A, Casamassimi A, Losito S, Ferraro P, Ciardiello F, Salomon DS, Normanno N (2000) Simultaneous blockade of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts. Oncogene 19:5863\u20135871","journal-title":"Oncogene"},{"key":"765_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012643","volume":"23","author":"SS Garg","year":"2022","unstructured":"Garg SS, Gupta J, Sahu D, Liu C-J (2022a) Pharmacological and therapeutic applications of esculetin. Int J Mol Sci 23:12643","journal-title":"Int J Mol Sci"},{"key":"765_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012643","author":"SS Garg","year":"2022","unstructured":"Garg SS, Gupta J, Sahu D, Liu CJ (2022b) Pharmacological and therapeutic applications of esculetin. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232012643","journal-title":"Int J Mol Sci"},{"key":"765_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202404148","volume":"10","author":"RK Gupta","year":"2025","unstructured":"Gupta RK, Priyadarshan A, Tiwari S, Patel Y, Bind AK, Tripathi G, Tripathi A, Kumar A, Dubey PK (2025) THPM (1, 2, 3, 4\u2010Tetrahydro pyrimidine) and berberine exhibit synergistic impact on inhibition of cell migration and colonization through ROS\u2010mediated apoptotic pathways in the breast cancer cells. ChemistrySelect 10:e202404148","journal-title":"ChemistrySelect"},{"key":"765_CR12","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1038\/sj.onc.1203973","volume":"19","author":"D Harari","year":"2000","unstructured":"Harari D, Yarden Y (2000) Molecular mechanisms underlying ErbB2\/HER2 action in breast cancer. Oncogene 19:6102\u20136114. https:\/\/doi.org\/10.1038\/sj.onc.1203973","journal-title":"Oncogene"},{"key":"765_CR13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nbt1007-1110","volume":"25","author":"AL Hopkins","year":"2007","unstructured":"Hopkins AL (2007) Network pharmacology. Nat Biotechnol 25:1110\u20131111","journal-title":"Nat Biotechnol"},{"key":"765_CR14","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1007\/s11030-024-10821-z","volume":"28","author":"J Jangra","year":"2024","unstructured":"Jangra J, Bajad NG, Singh R, Kumar A, Singh SK (2024) Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of Alzheimer\u2019s disease. Mol Divers 28:4381\u20134401","journal-title":"Mol Divers"},{"key":"765_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.15430\/jcp.2015.20.2.106","volume":"20","author":"YJ Jeon","year":"2015","unstructured":"Jeon YJ, Jang JY, Shim JH, Myung PK, Chae JI (2015) Esculetin, a coumarin derivative, exhibits antiproliferative and pro-apoptotic activity in G361 human malignant melanoma. J Cancer Prev 20:106\u2013112. https:\/\/doi.org\/10.15430\/jcp.2015.20.2.106","journal-title":"J Cancer Prev"},{"key":"765_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3892\/etm.2024.12536","volume":"27","author":"S Ju","year":"2024","unstructured":"Ju S, Tan Y, Wang Q, Zhou L, Wang K, Wen C, Wang M (2024) Antioxidant and anti-inflammatory effects of esculin and esculetin. Exp Ther Med 27:248","journal-title":"Exp Ther Med"},{"key":"765_CR17","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1073\/pnas.89.12.5321","volume":"89","author":"O-P Kallioniemi","year":"1992","unstructured":"Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen L-C, Smith HS, Waldman FM, Pinkel D, Gray JW (1992) ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci U S A 89:5321\u20135325","journal-title":"Proc Natl Acad Sci U S A"},{"key":"765_CR18","first-page":"8235","volume":"61","author":"PI Kauraniemi","year":"2001","unstructured":"Kauraniemi PI, B\u00e4rlund M, Monni O, Kallioniemi A (2001) New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61:8235\u20138240","journal-title":"Cancer Res"},{"key":"765_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s1470-2045(00)00254-0","volume":"2","author":"TJ Key","year":"2001","unstructured":"Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133\u2013140. https:\/\/doi.org\/10.1016\/s1470-2045(00)00254-0","journal-title":"Lancet Oncol"},{"key":"765_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/00498254.2021.1925774","volume":"51","author":"JH Kwak","year":"2021","unstructured":"Kwak JH, Kim Y, Staatz CE, Baek IH (2021) Oral bioavailability and pharmacokinetics of esculetin following intravenous and oral administration in rats. Xenobiotica 51:811\u2013817. https:\/\/doi.org\/10.1080\/00498254.2021.1925774","journal-title":"Xenobiotica"},{"key":"765_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27238367","volume":"27","author":"A Naeem","year":"2022","unstructured":"Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W, Zheng Q (2022) Natural products as anticancer agents: current status and future perspectives. Molecules 27:8367","journal-title":"Molecules"},{"key":"765_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40473-026-00334-4","volume":"13","author":"RS Negi","year":"2026","unstructured":"Negi RS, Kumar N, Behera J, Gond MKS, Singh AK, Mishra SK (2026a) Network pharmacology & bioinformatics insights elucidate garcinol as a promising natural MAO-B inhibitor for Alzheimer\u2019s disease. Curr Behav Neurosci Rep 13:17","journal-title":"Curr Behav Neurosci Rep"},{"key":"765_CR23","doi-asserted-by":"publisher","first-page":"9727","DOI":"10.1007\/s00210-026-05004-6","volume":"399","author":"RS Negi","year":"2026","unstructured":"Negi RS, Singh AK, Pathak AK, Gupta RK, Kumar N, Behera J, Gond MKS, Singh AK, Dubey PK, Mishra SK (2026b) Incorporation of network pharmacology, molecular docking, survival, density functional theory, and experimental studies to explore the potential key targets of formononetin by TERT-mediated anticancer effects in MCF-7 breast cancer. Naunyn Schmiedebergs Arch Pharmacol 399:9727\u20139744","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"765_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1021\/acs.jpcb.5c07771","volume":"130","author":"Z Qu","year":"2026","unstructured":"Qu Z, Wang Y, Yu H, Xu S (2026) Integrating network pharmacology to investigate the mechanism of ginsenoside compound K against coronavirus. J Phys Chem B 130:299\u2013310","journal-title":"J Phys Chem B"},{"key":"765_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/s0959-8049(97)10157-5","volume":"34","author":"F R\u00e9villion","year":"1998","unstructured":"R\u00e9villion F, Bonneterre J, Peyrat JP (1998) ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 34:791\u2013808. https:\/\/doi.org\/10.1016\/s0959-8049(97)10157-5","journal-title":"Eur J Cancer"},{"key":"765_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1948","volume":"7","author":"M Rezoan Hossain","year":"2024","unstructured":"Rezoan Hossain M, Zahra Shova FT, Akter M, Shuvo S, Ahmed N, Akter A, Haque M, Salma U, Roman Mogal M, Saha HR, Sarkar BC, Sohel M (2024) Esculetin unveiled: decoding its anti-tumor potential through molecular mechanisms-a comprehensive review. Cancer Rep 7:e1948. https:\/\/doi.org\/10.1002\/cnr2.1948","journal-title":"Cancer Rep"},{"key":"765_CR27","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1016\/j.bmc.2014.05.032","volume":"22","author":"S Sandhu","year":"2014","unstructured":"Sandhu S, Bansal Y, Silakari O, Bansal G (2014) Coumarin hybrids as novel therapeutic agents. Bioorg Med Chem 22:3806\u20133814. https:\/\/doi.org\/10.1016\/j.bmc.2014.05.032","journal-title":"Bioorg Med Chem"},{"key":"765_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.sajb.2024.01.035","volume":"166","author":"P Sharma","year":"2024","unstructured":"Sharma P, Dhiman T, Negi RS, Oc A, Gupta K, Bhatti JS, Thareja S (2024) A comprehensive review of the molecular mechanisms driving skin photoaging and the recent advances in therapeutic interventions involving natural polyphenols. S Afr J Bot 166:466\u2013482","journal-title":"S Afr J Bot"},{"key":"765_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/nzc2.70086","volume":"54","author":"P Sharma","year":"2026","unstructured":"Sharma P, Negi RS, Malik S, Patil UK, Thareja S (2026) An overview of phytochemistry and ethnopharmacological aspects of Myrica esculenta. N Z J Crop Hortic Sci 54:e70086","journal-title":"N Z J Crop Hortic Sci"},{"key":"765_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/290261a0","volume":"290","author":"C Shih","year":"1981","unstructured":"Shih C, Padhy LC, Murray M, Weinberg RA (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290:261\u2013264. https:\/\/doi.org\/10.1038\/290261a0","journal-title":"Nature"},{"key":"765_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149652","volume":"1859","author":"AK Singh","year":"2025","unstructured":"Singh AK, Pathak AK, Kumar P, Singh AK, Gond MKS, Negi RS, Das R, Agrawal S, Mishra SK, Tiwari KN (2025) Effects of Asiatic acid on brain cancer by altering astrocytes and the AKT1-PRKCB signaling pathway: a genomic and network pharmacology perspective. Brain Res 1859:149652","journal-title":"Brain Res"},{"key":"765_CR32","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1038\/onc.2016.129","volume":"35","author":"J Turpin","year":"2016","unstructured":"Turpin J, Ling C, Crosby EJ, Hartman Z, Simond AM, Chodosh LA, Rennhack JP, Andrechek ER, Ozcelik J, Hallett M (2016) The ErbB2\u0394Ex16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene 35:6053\u20136064","journal-title":"Oncogene"},{"key":"765_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc2127","volume":"7","author":"J Ursini-Siegel","year":"2007","unstructured":"Ursini-Siegel J, Schade B, Cardiff RD, Muller WJ (2007) Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat Rev Cancer 7:389\u2013397","journal-title":"Nat Rev Cancer"},{"key":"765_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jchromb.2016.03.027","volume":"1020","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao M, Ou Y, Zeng B, Lou X, Wang M, Zhao C (2016) Metabolic profile of esculin in rats by ultra high performance liquid chromatography combined with Fourier transform ion cyclotron resonance mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1020:120\u2013128. https:\/\/doi.org\/10.1016\/j.jchromb.2016.03.027","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"765_CR35","doi-asserted-by":"publisher","first-page":"113001","DOI":"10.1016\/j.biopha.2022.113001","volume":"150","author":"QH Wang","year":"2022","unstructured":"Wang QH, Qin SW, Jiang JG (2022) Improvement effects of esculetin on the formation and development of atherosclerosis. Biomed Pharmacother 150:113001. https:\/\/doi.org\/10.1016\/j.biopha.2022.113001","journal-title":"Biomed Pharmacother"},{"key":"765_CR36","doi-asserted-by":"crossref","unstructured":"Yavuz BR, Jang H, Nussinov R (2024) Anticancer target combinations: network-informed signaling-based approach to discovery. bioRxiv, 2024.2010. 2011.617918","DOI":"10.2139\/ssrn.4996073"},{"key":"765_CR37","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/molecules22071135","volume":"22","author":"H Yuan","year":"2017","unstructured":"Yuan H, Ma Q, Cui H, Liu G, Zhao X, Li W, Piao G (2017) How can synergism of traditional medicines benefit from network pharmacology? Molecules 22:1135","journal-title":"Molecules"},{"key":"765_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ptr.7311","volume":"36","author":"L Zhang","year":"2022","unstructured":"Zhang L, Xie Q, Li X (2022) Esculetin: a review of its pharmacology and pharmacokinetics. Phytother Res 36:279\u2013298. https:\/\/doi.org\/10.1002\/ptr.7311","journal-title":"Phytother Res"}],"container-title":["In Silico Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40203-026-00765-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40203-026-00765-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40203-026-00765-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:53:16Z","timestamp":1791309196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40203-026-00765-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["765"],"URL":"https:\/\/doi.org\/10.1007\/s40203-026-00765-7","relation":{},"ISSN":["2193-9616"],"issn-type":[{"value":"2193-9616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"22 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"255"}}